We are TotemID Biosciences Inc, an early-stage startup developing a platform nucleic acid-based assay technology that can be deployed in a point-of-care setting such as at home, without the need for expensive equipment or trained technicians. Our platform technology has implications for many illnesses, like COVID-19, the flu, or even cancer liquid biopsy. Our team recently completed Georgia Tech's Create-X: Startup Launch, a local startup accelerator, and a session of Creative Destruction Lab, an international startup incubator program. Our team is composed of PhD, MBV, and undergraduate students, and we have scientific and business advisors that are leaders in their respective fields.